Abstract
The article provides an analysis of the use of inhalation and oral ambroxol in the treatment of respiratory tract diseases in children and adults. The effectiveness of ambroxol, its safety and uniqueness of action are shown using numerous studies as an example. The article reveals the multifaceted pharmacological properties of ambroxol, its potential as a universal therapeutic agent for use by doctors of various specialties.
References
Mizgerd JP. Lung infection–a public health priority. PLoS Med. 2006;3(2):e76. doi: 10.1371/journal.pmed.0030076
Global Health Estimates 2021: Disease burden by Cause, Age, Sex, by Country and by Region, 2000–2021. Geneva: World Health Organization. (2024. Available online at: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/global-health-estimates-leading-causes-of-dalys (cited July 17, 2024).
Hay AD, Heron J, Ness A. Study Team ALSPAC. The prevalence of symptoms and consultations in pre-school children in the avon longitudinal study of parents and children (ALSPAC): a prospective cohort study. Fam Pract. 2005;22(4):367-74. doi: 10.1093/fampra/cmi035
Lu Cheng . Ambroxol hydrochloride spray (Luo Runchang®) in the treatment of acute respiratory infectious diseases: a prospective, multicenter, open label, randomized controlled study. Front. Pediatr. 05 September 2024. Sec. Pediatric Infectious Diseases . 2024;12. | https://doi.org/10.3389/fped.2024.1380189
Martin MJ, Harrison TW. Causes of chronic productive cough: an approach to management. Respir Med. 2015;109(9):1105-13. doi: 10.1016/j.rmed.2015.05.020
Nadel JA. Mucous hypersecretion and relationship to cough. Pulm Pharmacol Ther. 2013;26(5):510-3. doi: 10.1016/j.pupt.2013.02.003
Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010. 363(23):2233-47. doi: 10.1056/NEJMra0910061
Di Wu. Role of mucociliary clearance system in respiratory diseases. 2023 Feb 28;48(2):275-284. doi: 10.11817/j.issn.1672-7347.2023.220372